Enanta Pharmaceuticals
ENTA
#7465
Rank
NZ$0.70 B
Marketcap
NZ$24.37
Share price
-0.75%
Change (1 day)
64.54%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$96.4 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is NZ$96.4 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2025-09-30NZ$99.9 M14.29%
2024-09-30NZ$87.41 M97.66%
2023-09-30NZ$44.22 M-1.32%
2022-09-30NZ$44.81 M480.03%
2021-09-30NZ$7.72 M-36.82%
2020-09-30NZ$12.22 M3729.08%
2019-09-30NZ$0.31 M-27.8%
2018-09-30NZ$0.44 M-16.06%
2017-09-30NZ$0.52 M-27.95%
2016-09-30NZ$0.73 M-21.86%
2015-09-30NZ$0.93 M
2014-09-30N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$79.80 B 82,681.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$58.89 B 60,995.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$114.45 B 118,620.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$3.05 B 3,068.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$68.88 B 71,353.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$78.48 B 81,310.29%๐Ÿ‡บ๐Ÿ‡ธ USA